P/E ratio for Merit Medical (MMSI)
P/E ratio as of June 2023 (TTM): 56.5
According to Merit Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 56.5473. At the end of 2021 the company had a P/E ratio of 72.4.
P/E ratio history for Merit Medical from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 72.4 | -122.19% |
| 2020 | -327 | -194.13% |
| 2019 | 347 | 397.24% |
| 2018 | 69.8 | -4.72% |
| 2017 | 73.2 | 24.34% |
| 2016 | 58.9 | 71.06% |
| 2015 | 34.4 | 7.27% |
| 2014 | 32.1 | -20.48% |
| 2013 | 40.4 | 36.47% |
| 2012 | 29.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 33.1 | -41.55% | 🇺🇸 USA |
 Medtronic MDT | 27.5 | -51.45% | 🇮🇪 Ireland |
 Boston Scientific BSX | 87.0 | 53.85% | 🇺🇸 USA |
 Edwards Lifesciences EW | 34.9 | -38.24% | 🇺🇸 USA |
 Teleflex TFX | 30.6 | -45.81% | 🇺🇸 USA |
 ICU Medical
ICUI | -98.4 | -273.97% | 🇺🇸 USA |
 AngioDynamics ANGO | -11.5 | -120.41% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.